New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - methylphenidate hydrochloride 10mg;   - modified release capsule - 10 mg - active: methylphenidate hydrochloride 10mg   excipient: ammonio methacrylate copolymer gelatin macrogol 6000 methacrylic acid copolymer purified talc sugar spheres tekprint tan sw-8010 titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - methylphenidate hydrochloride 20mg;   - modified release capsule - 20 mg - active: methylphenidate hydrochloride 20mg   excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a-methacrylate acid-methacrylate copolymer 1:1, dry powder macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - methylphenidate hydrochloride 30mg;   - modified release capsule - 30 mg - active: methylphenidate hydrochloride 30mg   excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a/methacrylic acid methacrylate copolymer 1:1, dry powder iron oxide yellow macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - methylphenidate hydrochloride 40mg;   - modified release capsule - 40 mg - active: methylphenidate hydrochloride 40mg   excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a -/methacryllic acid-methacrylate coplymer 1:1 dry powder iron oxide black iron oxide red iron oxide yellow macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 60 mg/ml;  ;   - oral suspension - 60 mg/ml - active: oxcarbazepine 60 mg/ml     excipient: ascorbic acid citrus limon dispersible cellulose macrogol stearate 400 methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - methylphenidate hydrochloride 60mg;   - modified release capsule - 60 mg - active: methylphenidate hydrochloride 60mg   excipient: ammonio methacrylate copolymer gelatin iron oxide black iron oxide red iron oxide yellow macrogol 6000 methacrylic acid copolymer purified talc sugar spheres tekprint tan sw-8010 titanium dioxide triethyl citrate - ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - isradipine 2.5mg;  ;   - modified release capsule - 2.5 mg - active: isradipine 2.5mg     excipient: cetyl palmitate colloidal silicon dioxide gelatin hypromellose ink iron oxide yellow magnesium stearate microcrystalline cellulose titanium dioxide - treatment of hypertension

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - isradipine 5mg;  ;   - modified release capsule - 5 mg - active: isradipine 5mg     excipient: cetyl palmitate colloidal silicon dioxide gelatin hypromellose iron oxide yellow magnesium stearate microcrystalline cellulose tekprint red sw-1102 titanium dioxide - treatment of hypertension

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25 mg/ml;   - solution for injection - 75mg/3ml - active: diclofenac sodium 25 mg/ml   excipient: benzyl alcohol mannitol propylene glycol sodium hydroxide sodium metabisulfite water for injection - treatment of biliary colic.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 100mg;   - suppository - 100 mg - active: diclofenac sodium 100mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.